- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 293/06 - SelenazolesHydrogenated selenazoles
Patent holdings for IPC class C07D 293/06
Total number of patents in this class: 21
10-year publication summary
|
2
|
1
|
0
|
0
|
1
|
1
|
0
|
2
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Limited | 422 |
3 |
| Hangzhou Jennifer Biotech Co., Ltd. | 5 |
2 |
| Korea Institute of Science and Technology | 2255 |
1 |
| Cipla Limited | 473 |
1 |
| Emory University | 1727 |
1 |
| The Penn State Research Foundation | 1636 |
1 |
| Santen Pharmaceutical Co., Ltd. | 593 |
1 |
| Shenyang Pharmaceutical University | 124 |
1 |
| South China Agricultural University | 153 |
1 |
| Suzhou Kintor Pharmaceuticals, Inc. | 66 |
1 |
| Wenzhou University | 118 |
1 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 30 |
1 |
| Snu R&db Foundation | 579 |
1 |
| Atom Bioscience and Pharmaceutical Co., Ltd. | 4 |
1 |
| Syngenta Crop Protection AG | 56 |
1 |
| Helios Huaming Biopharma Co., Ltd. | 6 |
1 |
| Nanjing Synnocare Pharmaceutical Technology Co., Ltd. | 12 |
1 |
| Shanghai Synnocare Biopharmaceuticals Co., Ltd. | 3 |
1 |
| Other owners | 0 |